Latest news
Alps Group Posts 44% Revenue Growth in FY2026 as Nasdaq‑Listed Biotech Sharpens Precision Medicine Focus - TipRanksTipRanks · Fri, 07 Aug 2026 20:54:28 GMTExousia Bio Nearing Completion of Milestone Multimillion-Dollar Capital Investment - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 14:59:00 GMTDilated Cardiomyopathy Pipeline Expands as 8+ Companies Driving Innovation in the Therapeutics | DelveInsight - openPR.comopenPR.com · Thu, 30 Jul 2026 16:02:31 GMTROR Inhibitors Market Expected to Witness Significant Growth - openPR.comopenPR.com · Thu, 30 Jul 2026 15:52:57 GMTChronic Pruritus Market Expected to Witness Significant Growth - openPR.comopenPR.com · Thu, 30 Jul 2026 15:46:53 GMTExosomes Pipeline Expands as 100+ Companies Driving Innovation in the Therapeutics | DelveInsight - openPR.comopenPR.com · Thu, 30 Jul 2026 15:46:22 GMT